Thomas C Chen

Chief Scientific Officer

Thomas C Chen (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in NeOnc Technologies Holdings, Inc. (NTHI). Across 1 priced purchase filing, the average 21-session return was +17.4% from execution and -38.6% from disclosure (delay-adjusted; derived). The largest single filing was $130K of NTHI (33,787 sh × $3.85, as filed), executed Aug 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+17.4%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-38.6%

same 1 filings, from disclosure

Filings, ttm

2 buys · 0 sells · 1 late

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$260K

shares × price, as filed

Last traded

Aug 14

Filed Aug 20

Median ADV $730K across their filed names

Open performance→

Volume by month

Buys $260K Sells $1.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

NTHI

NeOnc Technologies Holdings, Inc. NTHI · 2 buys · 2 sells 4 filings

Recent filings

NTHIPURCHASE NeOnc Technologies Holdings, Inc. View filing → $130K
33,787 sh × $3.85
Exec Aug 14
Filed Aug 20 · 9:15 PM ET † NTHIPURCHASE NeOnc Technologies Holdings, Inc. View filing → $130K
33,787 sh × $3.85
Exec Aug 14
Filed Aug 18 · 4:13 PM ET NTHISALE NeOnc Technologies Holdings, Inc. View filing → $956K
38,250 sh × $25.00
Exec Mar 26 2025
Filed Apr 8 2025 · 5:30 PM ET † NTHISALE NeOnc Technologies Holdings, Inc. View filing → $956K
38,250 sh × $25.00
Exec Mar 26 2025
Filed Jun 5 2025 · 5:30 PM ET †